Navigation Links
UCSF receives $15 million to advance personalized medicine
Date:9/7/2010

e anti-diabetic drug metformin in African American patients with type 2 diabetes.

The field of membrane transporter pharmacogenomics has undergone enormous growth over the last decade, Giacomini said, and it is expected to have a significant impact on our understanding of pharmaceutical therapies over the next decade as well. In fact, the field of pharmacogenomics is expected to see enormous change, she said.

"Thanks to breakthroughs in genome sequencing technologies and our growing understanding of genetic variation among individuals, there has never been a better time to propel the field of pharmacogenomics," said NIH Director Francis S. Collins, MD, PhD. "Through these studies, we are moving closer to the goal of using genetic information to help prescribe the safest, most effective medicine for each patient."

Giacomini also will oversee a $3.2 million grant under the NIH program, to continue and expand a Global Alliance for Pharmacogenomics. This alliance involves NIH funded scientists in the Pharmacogenomics Research Network and scientists from the Center for Genomic Medicine, Riken, Yokohama, Japan.

The alliance will focus on large genomic studies of drug response from many drug classes, including those targeting cancer, asthma, cardiovascular disease and diabetes. The goal of the alliance is to identify genetic markers that determine both therapeutic and adverse drug responses in multiple racial and ethnic populations. These markers can eventually be used to guide drug therapy.

"This research requires analysis of vast amounts of data that can only be tackled through collaborative efforts among scientists and clinicians in many institutions," Giacomini said. "The global alliance will enable us to bring together the best and brightest in this field, from around Japan and the U.S., to achieve the goals of personalized medicines."

The new awards include 14 scientific research projects and seven network resou
'/>"/>

Contact: Kristen Bole
kristen.bole@ucsf.edu
415-502-6397
University of California - San Francisco
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Wistar Institute researcher receives New Innovator award from NIH
2. L-1 Identity Solutions Receives $5.9 Million Drivers License Contract Expansion from the State of Mississippi
3. Kount Receives Patent for Device Fingerprinting
4. American College of Medical Genetics receives $13.5M NIH contract
5. Penn State receives new NASA astrobiology grant
6. Global Viral Forecasting Initiative receives $11M to implement pandemic early warning system
7. Vidaza receives positve opinion from European CHMP
8. Case Western Reserve receives Ellison Medical Foundation New Scholar in Aging award
9. Montana State partnership receives $66.9M for carbon sequestration
10. Oklahoma EPSCoR receives $20 million for biofuels research
11. UC Riverside rice geneticist receives high honor from US Department of Agriculture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... French . ... with Alzheimer,s disease can be reversed with treatment. The study ... The Neuro, at McGill University and at Universit de Montral ... the brain of mice with advanced Alzheimer,s disease (AD) recovers ... Journal of Neuroinflammation in May, also suggest an underlying ...
(Date:6/16/2013)... cells use to group together and move around the body ... the first time by scientists at UCL. , Published ... on the process that occurs when cancer cells interact with ... metastasis. Scientists know that cancer cells recruit healthy cells and ... takes place and how it could be controlled to design ...
(Date:6/14/2013)... understanding and explaining how evolution operates. In search ... at Michigan State University developed complete evolutionary case ... underlying an evolving characteristic to their genetic consequences ... T. White, Merle K. Heidemann, and James J. ... a cellular and molecular biology course taught to ...
Breaking Biology News(10 mins):Blocking overactive receptor in Alzheimer's recovers memory loss and more 2'Chase and run' cell movement mechanism explains process of metastasis 2Teaching complete evolutionary stories increases learning 2
... Cancerous tumors are wildly unfavorable environments. Struggling ... the bodys defense systems, tumor cells in fact ... decades, scientists have sought ways to circumvent these ... University of Massachusetts Medical School (UMMS), have defined ...
... - BioMed Central today announced the launch of Biology ... over 11,000 carefully selected biology-related images. This is ... Science Navigation Group of companies which was also responsible ... resource. The Library is a new subscription-based service ...
... public health issue and economic problem has been ... the University Denis Diderot in Paris, and the ... chlorine-resistant parasites, known as Cryptosporidium, which cause a ... significant mortality in immunodeficient patients, become virtually inactive ...
Cached Biology News:Sidestepping cancer's chaperone 2Ultraviolet light helps to secure water supply 2
(Date:6/18/2013)... 2013 Demanding industrial and environmental conditions ... synthetic Sapphire and Glass Ball Lenses, now available in ... Jewel Company , of Philadelphia , PA. , Optical ... the light beams without the need for direct physical ... durability (9 mohs) make it the ideal choice for ...
(Date:6/18/2013)... RegeneCure announced today the start of a ... (GBR) Dental Membrane as a bone stimulating aid for patients ... patients have a tooth replaced with a dental implant is ... Consequently there is often a need to support the implant ... bone substitute material, in turn, needs to be held in ...
(Date:6/18/2013)... , June 18, 2013  AMRI (NASDAQ: ... Burlington, Mass. , site has ... Enforcement Administration (DEA) registration to handle Schedule 2 ... DEA,s acknowledgement of Burlington,s ... and documentation. (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) ...
(Date:6/18/2013)... 18, 2013 This webinar will ... advertising and promotion, and review the basic FDA ... how to apply these principles through real world ... ,     The fundamentals on FDA regulations and guidance ... ,     Assessing traditional and newer forms of ...
Breaking Biology Technology:Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2
... S.A., a,French drug and diagnostic discovery company, today announces ... 2007., 2007 Key Events, - Milestone reached ... AGN ) in view of the initiation of Phase ... - Approval by the AFSSAPS (Agence Francaise de ...
... Germany, March 5 In mid-March the German,Bundestag (Lower ... the German Stem,Cell Act. The opposing poles in the ... apart: its proponents are calling for the complete,liberalisation of ... of a,general ban on the use of human stem ...
... Statins Alone, in Decreasing Cardiovascular Events in Diabetics with Haptoglobin ... ... March 5 Synvista,Therapeutics, Inc. (Amex: SYI ) announces the publication ... E to statin therapy prevented more cardiovascular events (heart,attack, stroke and cardiovascular ...
Cached Biology Technology:ExonHit Therapeutics - 2007 Financial Results 2ExonHit Therapeutics - 2007 Financial Results 3ExonHit Therapeutics - 2007 Financial Results 4ExonHit Therapeutics - 2007 Financial Results 5ExonHit Therapeutics - 2007 Financial Results 6ExonHit Therapeutics - 2007 Financial Results 7ExonHit Therapeutics - 2007 Financial Results 8ExonHit Therapeutics - 2007 Financial Results 9ExonHit Therapeutics - 2007 Financial Results 10ExonHit Therapeutics - 2007 Financial Results 11ExonHit Therapeutics - 2007 Financial Results 12A New Era in Cell Biology: German Company Develops Groundbreaking Alternative to Stem Cell Therapy 2A New Era in Cell Biology: German Company Develops Groundbreaking Alternative to Stem Cell Therapy 3Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes 2Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes 3Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes 4
... 384 is a compact and self-contained ... is a unique flow-through device, which ... included wash system. Optional refill ... system. Will be upgradable to ...
This kit is designed to select cells labeled with phycoerythrin- (PE-) conjugated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
... Caliper's iLink makes it easy to ... laboratory instruments. Developed with operator convenience in ... and shoot' ease of use. The iLink ... workstations for assays or sub-assays, that can ...
... meet your laboratory's requirements for data management and quality control. ... ... ... the standard software for Staccato Systems and custom Allegro Modules allowing for the simple interface with ...
Biology Products: